Skip to main content

HCA Healthcare, Inc.

corporate_fare Company Profile

HCA Healthcare, Inc.

HCA·NYSE·Industrial Applications And Services·CIK 0000860730

HCA Healthcare, Inc. is a leading healthcare services company in the United States. As of December 31, 2025, the company operated 190 hospitals, which included 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. Additionally, HCA Healthcare operated 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers. Its facilities are located across 19 states and England. The company's primary goal is to deliver a wide range of quality healthcare services as cost-effectively as possible. Its general acute care hospitals offer comprehensive services for medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, alongside diagnostic and emergency services. Outpatient and supporting healthcare services are provided through its general acute care hospitals, ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centers, home health agencies, hospices, and rehabilitation facilities, among others. The behavioral hospitals provide a full spectrum of mental health care services in inpatient, partial hospitalization, and outpatient settings. HCA Healthcare, Inc. was incorporated in Delaware in October 2010, building on operations that began in 1968 through its predecessors. Its common stock is traded on the New York Stock Exchange under the symbol "HCA."

HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 30 items for HCA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for HCA spans 10-Q, 8-K.

Recent high-impact activity:

  • HCA Flags $550-650M Medicaid Payment Hit for 2027 as It Swaps $6.5B of Debt
  • HCA 10-Q Details Q3 Earnings: $1.579B Net Income, Uncompensated Care Up 24%
  • HCA Beats Q3 Estimates but $400M Uninsured Hit Sends Shares Down 4.7%
  • HCA Q3 EPS Rises 4.5% to $7.27; Full-Year Guidance Points to Upper Half of $28.70-$30.50 Range
  • HCA Guides FY EPS to $28.70-$30.50

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$75.6B
Net Income
$6.78B
Diluted EPS
$28.33
Op. Cash Flow
$12.64B
Free Cash Flow
$7.69B
Cash & Equivalents
$1.04B
Total Debt
$46.49B
Debt / Equity
-7.71×
Net Margin
9.0%
Shares Outstanding
224.61M sh
Source: 10-K · filed 2026-02-10 · accession 0001193125-26-044769

Short Interest & Short Volume

3.31 days to cover

FINRA reported short interest of 4,800,941 shares in HCA as of the October 30, 2026 settlement, a 2.1% decrease from the prior period — about 3.3 days to cover at its recent average daily volume. On November 20, 2026, 53.6% of HCA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,800,941 shares as of October 30, 2026
Change vs prior period▼ 2.1%
Days to cover3.31 at avg daily volume of 1,449,802
Daily short volume (FINRA facilities)53.6% of 544,895 shares on November 20, 2026
5-day average short volume50.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with H →
$476 +0.09% today
52-week range · as of 2026-10-29 $353.99 – $556.52
Market cap
$99.34B
Volume
1.6M (1.1× avg)
3-mo avg 1.4M
Live data · 2026-11-21 08:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCA - Latest Insights

HCA
Nov 09, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $499.00
Real-time Price: $476.00 info
Change: -$23.00 (-5%) info
Market Cap: $99.343B info
HCA
Oct 29, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $478.08
Real-time Price: $476.00 info
Change: -$2.08 (-0.44%) info
Market Cap: $99.343B info
HCA
Oct 27, 2026, 1:11 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $443.28
Real-time Price: $476.00 info
Change: +$32.72 (+7%) info
Market Cap: $99.343B info
HCA
Oct 27, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $485.00
Real-time Price: $476.00 info
Change: -$9.00 (-2%) info
Market Cap: $99.343B info
HCA
Oct 27, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.95
Real-time Price: $476.00 info
Change: +$15.05 (+3%) info
Market Cap: $99.343B info
HCA
Sep 15, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $423.00
Real-time Price: $476.00 info
Change: +$53.00 (+13%) info
Market Cap: $99.343B info
HCA
Jul 28, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $417.50
Real-time Price: $476.00 info
Change: +$58.50 (+14%) info
Market Cap: $99.343B info
HCA
Jul 24, 2026, 8:13 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $379.20
Real-time Price: $476.00 info
Change: +$96.80 (+26%) info
Market Cap: $99.343B info
HCA
Jul 24, 2026, 7:57 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $476.00 info
Change: +$107.00 (+29%) info
Market Cap: $99.343B info
HCA
Jul 24, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $476.00 info
Change: +$107.00 (+29%) info
Market Cap: $99.343B info
HCA
Jul 24, 2026, 7:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $476.00 info
Change: +$107.00 (+29%) info
Market Cap: $99.343B info
HCA
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $385.55
Real-time Price: $476.00 info
Change: +$90.45 (+23%) info
Market Cap: $99.343B info
HCA
Jul 19, 2026, 3:14 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $371.19
Real-time Price: $476.00 info
Change: +$104.81 (+28%) info
Market Cap: $99.343B info
HCA
Jul 14, 2026, 8:31 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $354.00
Real-time Price: $476.00 info
Change: +$122.00 (+34%) info
Market Cap: $99.343B info
HCA
Jul 14, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $368.00
Real-time Price: $476.00 info
Change: +$108.00 (+29%) info
Market Cap: $99.343B info
HCA
Jul 14, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $392.00
Real-time Price: $476.00 info
Change: +$84.00 (+21%) info
Market Cap: $99.343B info
HCA
Jun 18, 2026, 9:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $395.00
Real-time Price: $476.00 info
Change: +$81.00 (+21%) info
Market Cap: $99.343B info
HCA
May 27, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $392.15
Real-time Price: $476.00 info
Change: +$83.85 (+21%) info
Market Cap: $99.343B info
HCA
Apr 28, 2026, 6:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $448.70
Real-time Price: $476.00 info
Change: +$27.30 (+6%) info
Market Cap: $99.343B info
HCA
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $444.01
Real-time Price: $476.00 info
Change: +$31.99 (+7%) info
Market Cap: $99.343B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets